SOLIGENIX, INC. Preferred Stock, Value, Issued
SOLIGENIX, INC. (SNGX) had Preferred Stock, Value, Issued of $0 as of 2024-06-30, per its 10-Q filed 2024-08-09.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:PreferredStockValue · last filed 2024-08-09
- 2024-06-30: Preferred Stock, Value, Issued $0.00.
- 2024-03-31: Preferred Stock, Value, Issued $0.00.
- 2023-12-31: Preferred Stock, Value, Issued $0.00.
- 2023-09-30: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 |
| 2023-12-31 | $0.00 10-Q · filed 2024-08-09 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-21 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-13 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-14 |
| 2011-12-31 | $0.00 10-Q · filed 2012-05-14 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-12 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |